Nadilaz (Azelastine Hydrochloride, Fluticasone Propionate)

Azelastine is a selective H1‑histamine receptor antagonist. By blocking these receptors on nasal blood vessels and sensory nerves, it prevents histamine‑induced vasodilation, increased permeability and nerve stimulation, which reduces the immediate allergic symptoms such as itching, sneezing and watery discharge.

The dosage of Nadilaz is determined by the prescribing clinician based on the patient’s age, severity of symptoms and response to therapy. The prescriber will specify the number of sprays per nostril and the frequency, typically following the product’s labeling guidelines.

Safety data for Nadilaz in pregnancy and lactation are limited. Healthcare providers should weigh the potential benefits against any possible risks and consider alternative treatments if appropriate. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their physician.

To order Nadilaz, submit an enquiry on the product page at gnhindia.com, indicating the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and assistance with import documentation.

Nadilaz combines an antihistamine (azelastine) with a corticosteroid (fluticasone), offering both rapid relief of histamine‑mediated symptoms and longer‑term anti‑inflammatory control. Compared with monotherapy antihistamines or corticosteroids alone, the combination can provide more comprehensive symptom management, especially in patients with moderate to severe allergic rhinitis.

Nadilaz should be stored at room temperature, below 25 °C, in its original packaging. Keep the bottle tightly closed, protect it from moisture and direct sunlight, and avoid freezing. Do not refrigerate the product unless the manufacturer’s label specifically advises otherwise.

Nadilaz is administered as a nasal spray. The patient should gently blow the nose, tilt the head slightly forward, insert the nozzle into one nostril, and spray the prescribed number of sprays while breathing in gently. The same procedure is repeated in the other nostril if required.

Serious risks include severe allergic reactions such as anaphylaxis, systemic corticosteroid effects like adrenal suppression with prolonged use, and rare complications such as nasal septum perforation. Patients should seek immediate medical attention if they experience difficulty breathing, facial swelling, severe nosebleeds or signs of hormonal imbalance.

Nadilaz is contraindicated in individuals with known hypersensitivity to azelastine, fluticasone, or any of the formulation’s excipients. It should also be avoided in patients with active untreated nasal infections or recent nasal surgery unless directed by a physician.